Abstract | Dactylitis is diffuse swelling of the digits that is usually related to an underlying inflammatory or infiltrative disorder. Psoriatic arthritis (PsA) is the most common severe disease thought to cause dactylitis. Our understanding of the pathogenesis of PsA-related dactylitis comes from experimental animal models of PsA-like disease, as well as advances in imaging and other clinical studies. Clinical trials in PsA have increasingly included dactylitis as an important secondary outcome measure. These studies indicate that cytokines drive multi-locus microanatomical pan-digital pathology. Given the importance of pro-inflammatory cytokines, the pathogenesis of dactylitis is best understood as an initial aberrant innate immune response to biomechanical stress or injury , with subsequent adaptive immune mechanisms amplifying the dactylitis inflammatory response. Regarding the treatment of dactylitis, no studies have been conducted using dactylitis as the primary outcome measure, and the current knowledge comes from analysis of dactylitis as a secondary outcome measure.
1
. Approximately half of patients with psoriatic arthritis (PsA) have dactylitis at some point during the course of disease (usually in the early stages of PsA), but dactylitis can also occur in patients with other types of spondyloarthritis (SpA) (Box 1), including reactive arthritis and undifferentiated SpA 2 . The term 'sausage digit' is commonly used to describe the diffuse digital pathology typical of dactylitis 3 . Dactylitis can also be defined as uniform swelling such that the soft tissues between the metacarpophalangeal (MCP) and the proximal interphalangeal (PIP) and the distal interphalangeal (DIP) joints and the digital tuft ( Fig. 1) are diffusely swollen to the extent that the actual joint swelling can no longer be independently recognized 4 . Digital swelling that does not include the MCP or DIP region is also termed dactylitis and probably has the same underlying pathophysiology.
Dactylitis in psoriatic arthritis
Dactylitis is a characteristic musculoskeletal lesion of PsA (Fig. 2) . A seminal article outlining the importance of dactylitis in PsA showed that 260 out of 537 patients with PsA had dactylitis at some point, and almost 70% of these patients had dactylitis at the initial assessment 7 . In this study, more radiological damage was detected in digits with dactylitis than in those without 7 . However, the point prevalence of dactylitis in PsA is >50% in some contemporary studies that include TNF inhibitors and IL-17-IL-23 axis cytokine inhibitors (TaBle 1) . Moreover, the efficacy of such therapies probably aborts the natural history of dactylitis with its association with joint damage 7 .
Dactylitis types and triggers
Dactylitis is more common in the feet than in the hands and is often asymmetrical 7 . When the hands are involved, dactylitis typically involves the index finger of the dominant hand 7 . In the feet, the most commonly affected joint is the fourth toe, which is surprising given its relatively small size and anatomically protected location compared with the external facing first and fifth toes 7 . The greater involvement of the feet over the hands together with the pattern of hand disease has been interpreted as indicating that some kind of injury or trauma might trigger the disease. This interpretation led to the introduction of the idea of the deep Koebner phenomenon 11 , a skeletal variant of the cutaneous Koebner phenomenon that describes the onset of psoriasis and other dermatological disorders resulting from cutaneous injury or trauma. The deep Koebner phenomenon has been reported to contribute to the pathogenesis of PsA 12 , and injury is known to cause dactylitis in patients who are already genetically susceptible to PsA, with one study showing that identical twins developed disease in traumatized joints 13 . Biomechanical stress is well established as an initiating factor in SpA beyond the dactylitic lesion, especially from proofof-concept studies, such as those that show that skeletal mechanical strain can cause both entheseal inflammation and new bone formation in mouse models of The importance of dactylitis in SpA (including PsA) is further supported by its inclusion in the classification criteria developed by international groups, including the Classification Criteria for Psoriatic Arthritis (CASPAR) 5 and the Assessment of SpondyloArthritis International Society (ASAS) 6 . Dactylitis seems to have a prognostic value not only regarding the affected digit but also as a measure of PsA progression in general 7 .
The clinical importance of dactylitis in patients with PsA should not be underestimated, as dactylitis substantially impairs the basic motor functions required for daily living 8 .
Since the original theory that enthesitis is a lesion associated with the pathogenesis of dactylitis 9, 10 , progress has been made in our understanding of the microanatomy, mechanisms of disease and therapeutic options for treating dactylitis. Several experimental animal models develop dactylitis or dactylitis-like lesions and together with information on response to therapy in humans indicate that pro-inflammatory cytokines and various immune cells are central to the pathogenesis. SpA 14, 15 . A link between physical injury and PsA in general (not specifically dactylitis) is also well established in humans 16 . Furthermore, in animal models of SpA-like disease, increased physical stress triggers experimental arthropathy with features similar to PsA 14 . However, differences in pressure under the toes (as measured by accurate electronic systems such as pedography measurement platforms) do not account for differences between patients with PsA who have a history of dactylitis and those without 17 ; shear forces and footwear might account for these results.
Dactylitis scoring methods
In addition to dactylitis forming one of the classification criteria components of CASPAR for PsA 5 , the number of PsA clinical outcome measures has increased rapidly over the past few years 18 . Dactylitis scores are important inclusions in most of these measures, including the Composite Psoriatic Disease Activity Index (CPDAI) and the Psoriatic Arthritis Disease Activity Score (PASDAS) 19, 20 . In clinical trials, several methods for measuring dactylitis have been used 21 (TaBle 1) . Perhaps the most straightforward method is to count affected digits (score range 0-20) 19, 22 . Although this method has the advantage of simplicity, the reliability of the method has not been studied in borderline or debatable cases of dactylitis, in which it might have low inter-rater reliability. There is also the consideration of cold dactylitis (Box 2), in which dactylitic swelling occurs in the absence of pain or tenderness, which some clinicians and researchers discount as a manifestation of active disease. To circumvent this problem, some researchers have modified the simple count by grading each digit for the degree of tenderness, usually from 0 to 3, so that the combined score range is 0-60 (reFs 23, 24 ). One study combined a measure of digital circumference with a four point rating of tenderness by utilizing both the Leeds Dactylitis Index (LDI) (which is a function of finger circumference and tenderness, assessed and added across all dactylitic digits) 25 and the original version (in which tenderness is recorded as present or absent) 26 . Subsequent studies of PsA with both skin and joint assessments show that the LDI is reliable 27 and responsive to change in an observational longitudinal study 26 and in an interventional study of certolizumab pegol treatment for PsA 28 . The application of all these dactylitis scoring methods requires some important considerations for patients with PsA, such as whether these patients are obese. Deposition of fatty tissue on the digits can make dactylitis difficult to detect, and this difficulty is of particular importance given the high prevalence of obesity among patients with PsA. Given current knowledge regarding the pathogenesis of dactylitis, the typically diffuse digital pathology and the robust performance of existing outcome measures in trials, we believe the formulation of new clinically based outcome measures will not make a substantial difference to existing assessment methods.
Anatomy of dactylitis
Despite the diffuse clinical nature of dactylitis, the most characteristic lesion detected by imaging is flexor tenosynovitis. Unlike with rheumatoid arthritis (RA), the tenosynovitis lesion in dactylitis is often associated with diffuse extra-tendinous inflammation, termed pseudotenosynovitis 29 . The flexor tendons are constrained by accessory pulleys that are sites of complex patterns of combined compressive and tensile biophysical stress and have thus been likened to 'functional entheses' 30 . The accessory pulleys (Fig. 1) are at the interface between the tendon sheath and extracapsular soft tissues and are probably important structures in dactylitis pathogenesis but were historically difficult to visualize given their small size (Fig. 1) . However, recent high-resolution MRI of early dactylitis has shown inflammatory changes in the accessory pulleys (Fig. 2c,d probably all involve an inflammatory process that co-occurs in several tissues that might include bone marrow, periosteum, soft tissues and the skin 1, 4 . In children, dactylitis can be caused by sickle cell anaemia, in which the primary abnormality is osseous microvessel thrombosis with avascular necrosis 81 . This condition is particularly noteworthy, as the pathology is linked exclusively to inflammatory events taking place in the bone, with this osseous pathology probably triggering periosteal and diffuse adjacent soft tissue inflammatory responses. Severe periosteal and adjacent soft tissue inflammatory responses are also a feature of fractures and can manifest as diffuse soft tissue oedema. Notably, diffuse osseous inflammation or osteitis is also a major feature of PsA at multiple sites, including affected phalanges 82, 83 . Indeed, bone marrow oedema that probably represents osteitis has been detected by mRI in patients with dactylitis 37, 84 . Therefore, the osseous and associated periosteal inflammation might be a neglected and major contributory factor to soft tissue oedema in PsA (Fig. 2) . A strong link also exists between diffuse psoriatic osteitis and associated enthesitis 83 . These observations from other diseases in which dactylitis might occur as a result of bone pathology, for example, attest to the multifaceted pathogenesis of dactylitis. The anatomical relationship between the accessory pulleys A1-A5 and the flexor tendons (flexor digitorum profundus and flexor digitorum superficialis) seems to be important for flexor tenosynovitis, which is a common feature of dactylitis. As the finger joints move in the flexion and extension planes, the flexor tendons (enveloped within flexor tendon sheaths; not shown) move within the pulleys, thus creating a 'functional enthesis' with subsequent inflammation that can be diffuse along most parts or the whole of the finger, resulting in the characteristic 'sausage' swelling of dactylitis. There are multiple other entheses including collateral ligaments and nail-related entheseal anchorage networks around the digit. Sites of extensor tendon compression over the phalanges during flexion represent functional entheses that might be associated with dorsal extracapsular soft tissue inflammation.
mini-entheses that maintain proximity of tendons to the bone during movement. The anatomy of the human digit makes it unlikely that the nail is always integral to the dactylitic lesion; patients with PsA can have a dactylitic lesion of the proximal middle phalanx without lesions of the distal digit.
Imaging
Although psoriatic dactylitis is often evident on clinical examination and readily diagnosed, imaging is useful for the evaluation of less extensive disease or disease that is not clearly dactylitis, especially in patients with a high BMI. Ultrasonography and MRI are the main imaging techniques used for dactylitis assessment and are also useful for research purposes.
Ultrasonography. In general, ultrasonography can detect lesions including tenosynovitis, extracapsular inflammatory changes and abnormalities of the accessory pulleys 11, 29, 31, 32 . One ultrasonography study showed almost universal flexor tenosynovitis in a small group of patients with PsA and dactylitis, in addition to subcutaneous oedema and joint synovitis in 52% of the dactylitic digits 31 . In a power Doppler ultrasonography study of patients with PsA, pseudotenosynovitis was present in a quarter of patients with dactylitis, which provides further evidence of the diffuse nature of the inflammation 29 .
Pseudotenosynovitis occurs in the nonsynovial soft tissue and seems to correspond to accessory pulleys that are sites of stress (linked to restraining flexor tendons) caused by bowstringing (Fig. 3) . The importance of the extra-tendon soft tissue inflammation and small joint enthesophytes at flexor tendon insertions seen by ultrasonography has been shown in patients with PsA-related tenosynovitis but not with RA-related tenosynovitis 32 . This pattern of dactylitisrelated extra-tendon inflammatory change in the flexor compartment can be conceptualized as a 'rope on fire' (Fig. 3a) , with inflammation present in the vascular soft tissues adjacent to the relatively avascular tendon fascicles and accessory pulleys (Fig. 3) .
High-resolution ultrasonography was used in one study to image the accessory pulleys in patients with PsA and a history of dactylitis, patients with PsA and no history of dactylitis, patients with psoriasis, patients with RA or healthy individuals 11 .
The authors of this study tested whether high physical stress occurring between the accessory pulleys and the flexor tendons during finger movement might cause thickening of accessory pulleys as part of a deep Koebner phenomenon 11 . Indeed, pulleys were thicker in patients with PsA, especially in those with a prior history of dactylitis. Collectively, these imaging data support the importance of accessory minipulleys as initiators of tenosynovitis in dactylitis pathogenesis and not the flexor tendon insertion as originally thought 10, 33 . However, the diffuse nature of the dactylitis lesion, including diffuse osteitis, indicates that pathology in other tissues or heterogeneous mechanisms can lead to the same clinical outcome.
MRI.
MRI is a good imaging option for dactylitis and is superior to ultrasonography for imaging bone in individuals in which a diagnosis is not clear or in patients with underlying primary osteomyelitis or nonspecific soft tissue swelling of finger digits of unclear aetiology.
Early MRI and ultrasonography studies of PsA-related dactylitis showed predominant flexor tenosynovitis with occasional synovitis and soft tissue oedema in the hands, with similar changes evident in the feet 34, 35 . A follow-up study using the same imaging methods did not detect enthesitis in PsA-related dactylitis (despite a specific search for enthesitis), possibly reflecting the lower resolution of these imaging techniques at the time 36 . In a comprehensive MRI study of 17 patients with established PsA-related dactylitis, the severity of involvement and presence of nine features at each of the three joints of the digit (MCP joint, www.nature.com/nrrheum P e r s P e c t i v e s PIP joint and DIP joint) 37 were assessed. The nine features included synovitis, bone oedema, subcutaneous oedema, flexor tenosynovitis, extensor tenosynovitis, inflammatory changes of the plantar and/or volar plates and/or the collateral ligaments, erosions and sesamoiditis at the thumb and great toe 37 . Multiple structures in both dactylitic and non-dactylitic digits were abnormal on MRI; synovitis and soft tissue oedema were the most common abnormalities (in 69% of tender dactylitic digits), but bone oedema and flexor tenosynovitis were also detected. Soft tissue oedema (as shown in Fig. 1 ) tended to be circumferential around the digits and not limited to association with the flexor or extensor tendons.
High-resolution MRI has been used to show a close link between dactylitis and enthesitis within single digits 38 . In addition to abnormalities at the enthesis and extensor tendon functional entheses, prominent features include changes at the flexor tendon pulleys. The close juxtaposition of such lesions to the tendon sheaths offers an enthesis-related explanation for the pathology and explains inflammatory changes outside the flexor tendon sheaths and pseudotenosynovitis (as shown in Fig. 3b,d ). Iodine mapping with dual energy CT has been used to come to similar conclusions, showing enhancements at the site of accessory pulleys in patients with PsA 39 .
Dactylitis in animal models
The development of animal models for psoriasis and PsA is complicated for several reasons, including the dissimilarity between human and murine skin, with no model accurately recapitulating the PsA phenotype of psoriasis, axial and peripheral arthritis, nail disease, enthesitis and dactylitis 40 . Furthermore, the small size of murine digits with the close juxtaposition of the MCP, PIP and DIP joints has hampered an understanding of the immunopathogenesis of dactylitis. Indeed, several published studies on SpA-like disease seem to show images of dactylitis but do not mention the lesion 41 . The animal models of PsA-like disease indicate the importance of diffuse inflammation, a central function for T cells and innate immunity and a dependence on cytokines that have been successfully targeted to treat PsA-related dactylitis. DBA/1 model. Ageing male DBA/1 mice have been used as a model of PsA 42 . These mice developed dactylitis spontaneously in 6 of 50 paws from 33 male DBA/1 mice. Moreover, among the involved digits, subcutaneous oedema and neutrophilic infiltration were prominent (TaBle 2) . Using the same model, another study showed that spontaneous dactylitis mainly affected the fourth and fifth digits, and changing the housing conditions (larger cages and filter tops) affected the disease incidence PSTPIP2 model. Another animal model that results in dactylitis is dependent on mutations in Pstpip2 (which encodes mouse proline-serine-threonine phosphataseinteracting protein 2). These mice have an autosomal recessive macrophage-mediated autoinflammatory or innate immune disorder that develops spontaneously from the age of 6 weeks, with diffuse toe swelling and associated nail disease and eventual osteolysis 44 . Although the initial description of this model 44 did not use the term 'dactylitis' , prominent diffuse swelling of the digits was evident, and the data indicate that innate immune dysregulation in monocyte lineage cells with osteoclast activation was sufficient to drive an exclusively innate immune-mediated form of disease. In this model, extensive macrophage infiltration of the interphalangeal regions of the paws occurs 44 . 45 . These mice spontaneously develop autoimmune inflammatory arthritis characterized by the presence of high titres of autoantibodies, namely, rheumatoid factor and anti-type II collagen 46 . The model is dependent on the IL-17-IL-23 axis.
IL-23 overexpression model.
In one study, SKG mice housed in specific pathogen-free conditions and immunized with intraperitoneal injection of curdlan developed SpA-like arthropathy with dactylitis, deformities of the tail and colitis 47 . In these mice, dactylitis typically occurred 10 weeks after curdlan injection in ~40-50% of mice along with soft tissue inflammation and macrophage infiltration 47 . A subsequent study reported that arthritis and enthesitis in this model are dependent on IL-23, IL-22 and IL-17A without specifically referencing a dactylitis lesion 48 .
B10Q.Ncf1
m1j/m1j model. The B10Q.Ncf1
mouse model is characterized by impaired expression of the Ncf1 gene (which encodes a subunit of NADPH oxidase), resulting in the function of the NADPH oxidase 2 (NOX2) complexes being blocked. This model involves the intraperitoneal injection of mannan, resulting in enthesitis and dactylitis onset after 3 days, with dactylitis often present in the hind paws 49 . In this model, mice deficient in reactive oxygen species (ROS) production have exacerbated PsA-like disease, and restoration of ROS production limits skin and joint disease 49 .
The authors propose that mannan-induced TNF production from macrophages drives IL-17A-dependent enthesitis and dactylitis, with γδ T cells being the predominant source of IL-17A; however, the precise mechanisms regarding aberrant ROS expression in this model are not entirely understood.
Disease in this model has been shown to be independent of conventional T cells but dependent on TNF-producing myeloid cells and on IL-17A production, mainly from γδ T cells 49 (Fig. 4) . Koebner phenomenon following injury in ear tissue has also been reported to occur in the B10Q.Ncf1 m1j/m1j model, similar to the 'koebnerized' psoriatic skin characteristic of patients with psoriasis 11 . These experimental models are not without human comparisons, as the flexor tendon mini-enthesis accessory pulleys are thickened in patients with PsA in comparison with pulleys in patients with RA or psoriasis, possibly supporting the deep Koebner phenomenon as a causative factor 11 . 50 . In this model, the severity of skin and nail lesions and arthritis has been linked directly to prominent neutrophil inflammation in the digits and mini-entheses adjacent to the nails 50 .
STAT3 transgenic model.
K14-ARGE transgenic model. In the keratin 14 promoter amphiregulin gene (K14-ARGE) mouse model, overexpression of amphiregulin (an EGFR ligand) in the basal layers of the epidermis drives not only dermal inflammation but also underlying synovitis 51 . This PsA-like disease model involves skin pathology that has spread into deeper tissues, similar to dactylitis.
JunB/cJun knockout model. In a study of another PsA-like disease model, the inducible epidermal deletion of the transcription factor JUNB and its functional companion cJUN resulted in psoriasis and underlying arthritic lesions 52 . This study did not specifically address the possibility of subcutaneous inflammation linking the skin involvement to the underlying joints. The idea that the epidermis and skin barrier are crucial in the pathogenesis of dactylitis in humans might 118 | FeBRuARY 2019 | volume 15
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Box 2 | Other forms of dactylitis
Rather surprisingly, the issue of tenderness and pain in dactylitis has been somewhat overlooked by physicians. one of the problems with the definition of dactylitis is that a chronic non-tender form exists in some patients with psoriatic arthritis 7 . The lack of tenderness might suggest inactive disease, but imaging might also reveal unrecognized synovitis and soft tissue oedema, demonstrating that the difference between tender and non-tender dactylitis is quantitative, not qualitative 37 . Whether this so-called cold dactylitis is predominantly a chronic reactive process related to tissue remodelling or an inflammatory reaction is not completely understood. Histopathology studies have not yet compared different types of dactylitis (such as cold dactylitis) to resolve this issue. In one case study, soft tissue lymphocyte infiltration was shown in a symptomatic patient with dactylitis be relevant in patients with nail involvement or digital psoriasis given these insights from animal models of PsA-like disease 9 . A synthesis of the various animal model studies can be used to propose a model of dactylitis pathogenesis (Fig. 4) .
Human immunogenetic studies
Anterior uveitis, axial SpA and psoriasis with their respective HLA-B27 associations for ocular and joint disease and HLA-Cw0602 with psoriasis are collectively linked with severe, early-onset disease, which points towards the importance of adaptive immunity in driving these diseases 53 .
Dactylitis is also associated with HLAB*2705 (reF.
54
), whereas HLAC*0602 is associated with patients with PsA being protected from developing dactylitis 55 . The initial studies (reviewed elsewhere 56 ) have shown a link between dactylitis and HLAB*0801 (reF.
56
). Collectively, these MHC class I associations indicate a potential function for CD8 + T cells in driving disease in the dactylitis lesion, but this needs confirmation, as MHC class I disease associations might involve other mechanisms beyond classical antigen presentation to CD8 + T cells 57 . Interestingly, the alleles associated with dactylitis, HLAB*2705 and HLAB*0801, are also linked to enthesitis and synovitis, respectively, which might reflect the diffuse and multi-site inflammatory changes that typify dactylitis 56 . A simplistic immunological model for dactylitis would involve an extensive immune reaction to common antigens present at multiple sites in the different inflamed digital tissues (Fig. 4) . However, human data to firmly support this concept are currently lacking.
Dactylitis therapy
NSAIDs. NSAIDs can be prescribed for dactylitis; however, dactylitis can progress even if treated with NSAIDs 58 . Controlled trials have not yet provided evidence to support the use of NSAIDs in PsA-related dactylitis.
Glucocorticoids. As many patients with dactylitis are not responsive to NSAIDs, many clinicians recommend injection of corticosteroids into the tenosynovial sheath, joint or soft tissues. However, controlled studies to assess the efficacy of such a strategy have not been conducted.
Conventional DMARDs.
In patients who are resistant to NSAIDs and injected corticosteroids, DMARDs are often used; however, this almost always occurs in the context of coexisting active disease other than digital inflammation, so guidance for the use of DMARDs in cases of isolated dactylitis are lacking. Nevertheless, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) advocates the use of DMARDs including methotrexate, and EULAR PsA recommendations do not advocate the use of methotrexate but do suggest direct initiation of a biologic therapeutic 59, 60 . One open-label study analysing data from volume 15 | FeBRuARY 2019 | 119 NATuRe RevIeWS | RhEuMATOlOGy P e r s P e c t i v e s 60 . Obviously, synovitis (including that which occurs in the MCP, PIP, DIP joints and flexor tendon) is an integral part of the dactylitis lesion. However, it is difficult to understand the endorsement of methotrexate for synovitis in small joints but not for dactylitis; tenosynovitis and synovitis are integral features of dactylitis (Fig. 5) . This confusion probably reflects the paucity of data on dactylitis therapy.
Biologic therapeutics.
No clinical trial for biologic therapeutics in PsA has been conducted using dactylitis as the primary outcome measure, and most of the knowledge of the efficacy of various biologic agents comes from analysis of dactylitis as a secondary outcome measure (TaBle 1) . Most studies have used unvalidated measures of dactylitis, and the most recent recommendations from GRAPPA suggest that biologic therapy should be initiated only after DMARD failure in patients with dactylitis 62 . Also, the point prevalence of dactylitis is remarkably high in some phase III PsA trials 63, 64 of biologic therapeutics or small molecules (TaBle 1) compared with large real world studies in which the calculated prevalence of dactylitis was <40% 2 . Whether this high prevalence calculation of dactylitis in some phase III trials (TaBle 1) is accurate or affected by other factors (such as obesity) needs further study; application of ultrasonography or MRI in clinical trials might bring clarity to this point.
Substantial improvements in dactylitis have been noted in a variety of clinical trials. These trials include certolizumab pegol (TNF inhibitor) treatment in the RAPID-PsA trial 28 and ustekinumab (IL-12 and IL-23 inhibitor) treatment in the PSUMMIT-1 and PSUMMIT-2 trials 63 . Also, phase II studies of golimumab (TNF inhibitor) in the GO-REVEAL trials 65, 66 , infliximab (TNF inhibitor) in the IMPACT1 (reF.
67
) and IMPACT2 (reF.
68
) trials and a combination of infliximab plus methotrexate compared with methotrexate alone in an open-label study 69 showed improvements in dactylitis, as did adalimumab (TNF inhibitor) in prior treatment failures in other openlabel studies. Molecular imaging with radiolabelled certolizumab pegol showed substantial TNF expression along the dactylitic digit in humans 70 , providing compelling evidence for the function of this cytokine in the dactylitis lesion.
Other studies have shown efficacy for the IL-17A blockers secukinumab (FUTURE 3 (reF.
71
) and FUTURE 5 (reF. and ixekizumab (SPIRIT-P1 (reF. (TaBle 1) . Collectively, these studies confirm the importance of both the TNF and IL-23-IL-17 signalling pathways in dactylitis pathogenesis.
Tofacitinib (an oral Janus kinase inhibitor) 64, 75 and abatacept (a selective T cell co-stimulation inhibitor) 76 
Glossary

Bowstringing
The natural tendency of the tendon to pull away from bone surface on the flexor aspect, which is being restrained by the accessory pulleys.
Cold dactylitis
Dactylitis swelling without pain or tenderness.
Deep Koebner phenomenon
The skeletal counterpart of skin injury in the Koebner phenomenon, whereby enthesis and joint injury can be associated with psoriatic arthritis development.
Digital tuft
The terminal bony prominence at the end of the distal interphalangeal digits.
Koebner phenomenon
The appearance of skin lesions in areas of cutaneous trauma, mainly (but not only) in patients with psoriasis.
Minicircle technology
a method for introduction of DNa into somatic cells with resultant protein expression.
Sesamoiditis
inflammation of the sesamoid bones and/or their supporting structures.
of dactylitis might be relevant for understanding why anti-IL-17A therapy seems to be a better therapy for synovitis and tenosynovitis in patients with PsA than for patients with RA 80 . Thus, the therapeutic importance of these pathways seems to be confined to PsA-related tenosynovial or synovial disease and helps us to conceptualize a model of joint inflammation in dactylitis (Fig. 4) .
Collectively, these available therapeutic studies show that, unlike for enthesitis, therapy results in complete resolution of dactylitis in the majority of patients (TaBle 1) . This difference might reflect the fact that dactylitis has fewer differential diagnoses than entheseal pain, with the resolution of diffuse digital swelling in dactylitis being an objective measure of inflammation resolution for this lesion in PsA. However, the more subjective nature of isolated enthesitis assessment, and the absence of swelling in most cases of enthesitis, makes it more difficult to assess inflammation as a cause of pain for that lesion.
Conclusions
The microanatomical and immunopathogenic basis for understanding experimental dactylitis is helpful and informs our understanding of human dactylitis, but translation of results from animal models to humans requires further study. Experimental models and human studies indicate that dactylitis involves inflammation in multiple tissues including bone, periosteum, entheses, perientheseal and peri-tendinous soft tissue, tenosynovium and articular synovium. The inflammation is most conspicuous in the vascular tissues adjacent to the relatively avascular tendons, pulleys and entheses (Fig. 3) . This pattern distinguishes the inflammation of dactylitis from RA in which inflammation is generally maximal within synovial cavities. Further studies are needed to explore exactly how the innate and adaptive immune responses are triggered in dactylitis. Advances in imaging might also be required to identify how quickly and how well dactylitis lesions resolve in order to define optimal therapeutic strategies for PsA. The dactylitis phenotype in PsA is an intriguing (but treatable) lesion, but more evidence is required for a complete understanding of its pathogenesis. Some recommendations eschew the use of methotrexate for dactylitis, which typically involves the tendons and joints in the same digit (group A joints), and suggest going straight to treatment with a biologic therapeutic. However, if synovitis or tenosynovitis is present in a non-dactylitic pattern in a patient with PsA (for example, adjacent metacarpophalangeal joints as in group B joints), then methotrexate and other DMARDs such as sulfasalazine are generally recommended.
